9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
National Institutes of Health Clinical Center (CC)
QuantumLeap Healthcare Collaborative
Università Vita-Salute San Raffaele
UNICANCER
University of Kentucky
Weill Medical College of Cornell University
AbbVie
Sun Yat-sen University
Shandong Cancer Hospital and Institute
The First Affiliated Hospital of Guangzhou Medical University
Puma Biotechnology, Inc.
Loyola University
Fudan University
University of Manchester
Shanghai Changzheng Hospital
NYU Langone Health
Quest PharmaTech Inc.
Heat Biologics
Belgian Gynaecological Oncology Group
UConn Health
NYU Langone Health
Stanford University
Genentech, Inc.
Fox Chase Cancer Center
Massachusetts General Hospital
Shenzhen Hornetcorn Bio-technology Company, LTD
Mateon Therapeutics
AstraZeneca
University of Michigan Rogel Cancer Center
AstraZeneca
AstraZeneca
GlaxoSmithKline
Mateon Therapeutics
Amgen
Seattle Cancer Treatment and Wellness Center